Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
NC
Neo Coating Pharma ApS
aktivCVR 28668570AnpartsselskabHøffdingsvej 34, 2500 ValbyOpførelse af bygninger
- Latest accounts
- 2026
- Statement scope
- Standalone
- Verified
- 06 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2026
Revenue
Data quality concern—
Data quality concern
Operating profit
DKK -30.7k
Latest period
Source details
Source: dk-regnskabsdata-live-28668570-1793933665997
Document: dk-regnskabsdata-28668570-AaClMStdvHjT2SSoadqC-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jul 2025 - 30 Jun 2026
Technical details
Context: ID_0
Unit: DKK
Net result
DKK -23.8k
Latest period
Source details
Source: dk-regnskabsdata-live-28668570-1793933665997
Document: dk-regnskabsdata-28668570-AaClMStdvHjT2SSoadqC-1
XBRL: fsa:ProfitLoss
Period: 01 Jul 2025 - 30 Jun 2026
Technical details
Context: ID_0
Unit: DKK
Equity
DKK 410.7k
Equity ratio: 94.6%
Source details
Source: dk-regnskabsdata-live-28668570-1793933665997
Document: dk-regnskabsdata-28668570-AaClMStdvHjT2SSoadqC-1
XBRL: fsa:Equity
Period: 01 Jul 2025 - 30 Jun 2026
Technical details
Context: ID_13
Unit: DKK
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | — | DKK 105.2k |
| 2023 | — | — |
| 2024 | — | DKK -133.4k |
| 2025 | — | DKK -29.3k |
| 2026 | — | DKK -23.8k |